MKMarta Klimczak

Marta Klimczak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Klimczak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Blasiak

    Department of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Krakow, Poland

    1 shared publication
  • Anna Bryksa

    Department of Molecular Neuropharmacology, Maj Institute of Pharmacology of the Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland

    1 shared publication
  • Jadwiga Spyrka

    Department of Neurophysiology and Chronobiology, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University, Gronostajowa 9, 30-387 Krakow, Poland

    1 shared publication
  • Jan Rodriguez Parkitna

    Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences

    1 shared publication
  • Joanna Zajdel

    Department of Molecular Neuropharmacology, Maj Institute of Pharmacology of the Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland

    1 shared publication
  • Kamila Jastrzębska

    Department of Molecular Neuropharmacology, Maj Institute of Pharmacology of the Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland

    1 shared publication

Latest Publications

  • Open Access

    Loss of mu and delta opioid receptors on neurons expressing dopamine receptor D1 has no effect on reward sensitivity

    by Zofia Harda, Jadwiga Spyrka, Kamila Jastrzębska, Łukasz Szumiec, Anna Bryksa, Marta Klimczak, Maria Polaszek, Sławomir Gołda, Joanna Zajdel, Anna Błasiak, et al.

    Opioid signaling controls the activity of the brain’s reward system. It is involved in signaling the hedonic effects of rewards and also has essential roles in reinforcement and motivational processes. Here, we focused on opioid signaling through mu and delta receptors on dopaminoceptive neurons and evaluated the role these receptors play in reward-driven behaviors. We generated a genetically modified mouse with selective double knockdown of mu and delta opioid receptors in neurons expressing dopamine receptor D1. Selective expression of the transgene was confirmed using immunostaining. Knockdown was validated by measuring the effects of selective opioid receptor agonists on neuronal membrane currents using whole-cell patch clamp recordings. We found that in the nucleus accumbens of control mice, the majority of dopamine receptor D1-expressing neurons were sensitive to a mu or delta opioid agonist. In mutant mice, the response to the delta receptor agonist was blocked, while the effects of the mu agonist were strongly attenuated. Behaviorally, the mice had no obvious impairments. The mutation did not affect sensitivity to the rewarding effects of morphine injections or social contact and had no effect on preference for sweet taste. Knockdown had a moderate effect on motor activity in some of the tests performed, but this effect did not reach statistical significance. Thus, we found that knocking down mu and delta receptors on dopamine receptor D1-expressing cells does not appreciably affect reward-driven behaviors. Highlights: – It is well accepted that opioid signaling controls the brain’s reward system – We generated mutant mice with mu and delta receptor knockdown in D1 neurons – Knockdown made dopaminoceptive neurons insensitive to mu and delta opioid receptor agonists – The mutation did not cause obvious behavioral impairments – The loss of mu and delta receptors on D1 neurons does not affect reward sensitivity